Derniers articles

Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial

AbstractBackground: The impact of adapted physical activity (APA) on health-related quality of life (HRQoL) in...

Posté par : Mme. Julie HENRIQUES
Nom de la revue : J Natl Compr Canc Netw.

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

AbstractPurpose: Patients with oligometastasis may have prolonged survival with multisite stereotactic ablative...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Int J Radiat Oncol Biol Phys

SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors

AbstractBackground: Sunitinib, a multitarget tyrosine kinase inhibitor, showed encouraging antitumor activity and...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Ther Adv Med Oncol

Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial

AbstractBackground and objective: The CABASTY study showed that more frequent administration of a lower dose of...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : European Urology Oncology

New Biomarkers to Define A Biological Borderline Situation for Pancreatic Adenocarcinoma - Results of An Ancillary Study of the PANACHE01-PRODIGE48 Trial.

AbstractObjective: To investigate in patients treated for a resectable pancreatic ductal adenocarcinoma (PA), the...

Posté par : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Nom de la revue : Annals of Surgery

A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study

AbstractBackground: The planification of radiation therapy (RT) for pancreatic cancer (PC) requires a dosimetric...

Posté par : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Nom de la revue : Radiation Oncology

A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial

AbstractBackground: We assessed the added value of incorporating carcinoembryonic antigen (CEA) to circulating...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : The Oncologist

Real-life data on biliary tract cancers in France: The nested Amber study from the French ACABi GERCOR PRONOBIL retro-prospective, observational cohort

AbstractKeywords: Biliary tract cancer; CisGem; Molecular profile; Real-life data.

Posté par : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Nom de la revue : Digestive and Liver Disease

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer

AbstractContext and aims: Eribulin is used in taxane and anthracycline refractory HER2-negative metastatic breast...

Posté par : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Nom de la revue : Clin Breast Cancer.

Interaction analysis of subgroup effects in randomized trials: the essential methodological points

AbstractSubgroup analysis aims to identify subgroups (usually defined by baseline/demographic characteristics), who...

Posté par : Dr. Dewi VERNEREY
Nom de la revue : Sci Rep.

Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort Study

AbstractBackground: Stage II colon cancer (CC) exhibits considerable prognostic heterogeneous. Our objective was to...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Clin Colorectal Cancer.

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases

AbstractBackground: Small bowel adenocarcinoma is a rare disease. The genomic profiling tumours according to...

Posté par : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Nom de la revue : Br J Cancer.

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

AbstractBackground: One randomized phase III trial comparing chemotherapy (CT) with immune checkpoint inhibitors...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : Eur J Cancer.

Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations

AbstractPurpose: To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been...

Posté par : Mme. Aurélia MEURISSE
Nom de la revue : Support Care Cancer

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study

AbstractBackground: The modified docetaxel, cisplatin, and fluorouracil (mDCF) regimen has shown efficacy and...

Posté par : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Nom de la revue : Lancet Oncol.

Does Kono-S Anastomosis Reduce Recurrence in Crohn's Disease Compared with Conventional Ileocolonic Anastomosis? A Nationwide Propensity Score-matched Study from GETAID Chirurgie Group [KoCoRICCO Study]

AbstractBackground and aims: Postoperative recurrence is a major concern in Crohn's disease. The Kono-S anastomosis...

Posté par : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Nom de la revue : J Crohns Colitis.

Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort

AbstractBackground & aims: Accumulating data has shown the rising incidence and poor prognosis of early-onset...

Posté par : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Nom de la revue : Liver Int.

Publications (2024)